Prescription Drug Litigation

When people have been injured by defective drugs or medical devices, SimmonsCooper has helped them stand up, speak out, and get the compensation they deserve.  We have a team of experienced attorneys that can handle your case and help you navigate the complicated world of pharmaceutical litigation.

Today, SimmonsCooper continues to work on the front lines of several groundbreaking pharmaceutical trials, including several on a national stage. We have represented thousands of pharmaceutical clients and recovered more than $200 million in verdicts and settlements.*

SimmonsCooper has experience in litigating complex medical matters. We have taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs. 

In pharmaceutical and medical device litigation, our success comes from our thorough understanding of our clients’ particular medical history, weighed against the manufacturers’ legal obligations for testing, warnings and labels.

We have concentrated practice areas in: 

Reglan
Byetta
PPHN Birth Injuries
Avandia
NSF / Gadolinium
Digitek
Trasylol
Zelnorm
Vioxx
Bextra
Ephedra and PPA
Heart Devices
Hormone Replacement Therapy (HRT)
Ortho Evra

For more information about how we identify potentially dangerous drugs and to determine a manufacturer’s liability, click here.

^{* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.}

Resources for Clients

Prescription for Trouble
healthfinder Resources for Arthritis
Merck & Co., Inc.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Medwatch
New England Journal of Medicine
American Heart Institute
American Stroke Association 

News

• St. Louis Commerce Magazine Features Firm's Work for Military Veterans and Cancer Research
• FDA ADVISORY: Gadolinium Linked to Serious Health Risks
• MEDICAL ALERT: Diabetes Drug Avandia Linked to Heart Attacks
• MEDICAL ALERT: SSRI Antidepressants Linked to Cognitive and Developmental Deficits